The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant Klebsiella pneumoniae in Zhejiang Province, China

Ceftazidime-avibactam (CAV) is a new treatment option against carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. However, the rapid emergence of CAV resistance mediated by KPC variants has posed a severe threat to healthcare after its clinical application. The characteristics of CAV resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Congcong, Wu, Yuchen, Huang, Ling, Zhang, Yanyan, Sun, Qiaoling, Lu, Jiayue, Zeng, Yu, Dong, Ning, Cai, Chang, Shen, Zhangqi, Chen, Gongxiang, Zhang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219983/
https://www.ncbi.nlm.nih.gov/pubmed/35740138
http://dx.doi.org/10.3390/antibiotics11060731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219983/
https://www.ncbi.nlm.nih.gov/pubmed/35740138
http://dx.doi.org/10.3390/antibiotics11060731

Ejemplares similares